Clinical Trials: Drug Interventions Starting with Non-Letters
- (1-6)-alpha-glucomannan 6 studies
- (3-aminopropyl)(n-butyl)phosphinic acid 1 study
- 1 alpha,24-dihydroxyvitamin D3 2 studies
- 1 alpha-hydroxyergocalciferol 20 studies
- 1,3-dipropyl-8-(3-noradamantyl)xanthine 6 studies
- 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid 3 studies
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine 8 studies
- 1-(carboxymethylthio)tetradecane 1 study
- 1-hydroxycholecalciferol 27 studies
- 10-deazaaminopterin 12 studies
- 10-hydroxycamptothecin 6 studies
- 11-hydroxyprogesterone 21 studies
- 17-alpha-hydroxy-progesterone caproate 21 studies
- 2',3'-dideoxy-5-fluoro-3'-thiacytidine 3 studies
- 2'-deoxy-2'-(fluoromethylene)cytidine 3 studies
- 2'-fluoro-5-methylarabinosyluracil 28 studies
- 2,3-dihydro-1H-imidazo(1,2-b)pyrazole 2 studies
- 2,4-thiazolidinedione 72 studies
- 2,5-Dimethoxy-4-Methylamphetamine 1 study
- 2,6-diaminopurine 1 study
- 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide 4 studies
- 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid 1 study
- 2-Aminopurine 12 studies
- 2-chloro-3'-deoxyadenosine 15 studies
- 2-methoxyestradiol 9 studies
- 3'-azido-3'-deoxythymidine 5'-triphosphate 1 study
- 3,3'-diindolylmethane 1 study
- 3,4-diaminopyridine 14 studies
- 3,4-dihydroxyphenylethanol 1 study
- 3,4-Methylenedioxyamphetamine 21 studies
- 3-(2,4-dimethoxybenzylidene)anabaseine 4 studies
- 3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide 1 study
- 3-Iodobenzylguanidine 42 studies
- 3-keto-desogestrel 27 studies
- 3-n-butylphthalide 3 studies
- 4'-deoxydoxorubicin 4 studies
- 4'-N-benzoylstaurosporine 17 studies
- 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol 15 studies
- 4-Aminopyridine 30 studies
- 4-des-dimethylaminotetracycline 5 studies
- 4-Hydroxycoumarins 2 studies
- 4-hydroxytamoxifen 3 studies
- 4-phenylbutyric acid 37 studies
- 4-tert-butyl-4'-methoxydibenzoylmethane 1 study
- 5,6-dimethylxanthenoneacetic acid 18 studies
- 5-(1-aziridinyl)-2,4-dinitrobenzamide 1 study
- 5-alpha Reductase Inhibitors 125 studies
- 5-chloro-2-methyl-4-isothiazolin-3-one 1 study
- 5-ethynyluracil 11 studies
- 5-Hydroxytryptophan 7 studies
- 5-methoxypsoralen 2 studies
- 6-Aminocaproic Acid 13 studies
- 6-Mercaptopurine 128 studies
- 6-O-palmitoylascorbic acid 2 studies
- 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester 2 studies
- 7-hydroxystaurosporine 22 studies
- 8-chloro-cyclic adenosine monophosphate 2 studies
- 8-epi-prostaglandin F2alpha 1 study
- 9-amino-20-camptothecin 10 studies
- 9-hydroxy-risperidone 128 studies
- 9-nitrocamptothecin 24 studies
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/browse/intr_alpha_other
